JNJ
36
3
BWA
49
-6
HCA
44
4
MAR
62
-3
CVX
23
-2
RL
75
3
QCOM
55
2
TSN
28
-2
KEY
31
2
MLM
41
-2
IPG
49
2
EA
50
-2
GOOGL
67
-2
WBA
64
4
VRSK
63
-3
STX
42
-2
CCI
23
-2
VZ
39
2
AMG
54
-4
MRK
33
3
JNJ
36
3
BWA
49
-6
HCA
44
4
MAR
62
-3
CVX
23
-2
RL
75
3
QCOM
55
2
TSN
28
-2
KEY
31
2
MLM
41
-2
IPG
49
2
EA
50
-2
GOOGL
67
-2
WBA
64
4
VRSK
63
-3
STX
42
-2
CCI
23
-2
VZ
39
2
AMG
54
-4
MRK
33
3
Financhill
Back

Humacyte Quote, Financials, Valuation and Earnings

Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!

Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)
Sell
34

HUMA
Humacyte

Last Price:
4.11
Seasonality Move:
-6.86%

7 Day Trial

ALL ACCESS PASS

$ 7

The dark truth about AI

Click here to learn more...

Humacyte Price Quote

$4.11
+0.01 (+0.74%)
(Updated: December 14, 2024 at 5:37 AM ET)

Humacyte Key Stats

Sell
34
Humacyte (HUMA) is a Sell
Day range:
$4.01 - $4.22
52-week range:
$2.48 - $9.97
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%
Volume:
1.6M
Avg. volume:
3M
1-year change:
40.89%
Market cap:
$525M
Revenue:
$0
EPS:
$-1.34

How Much Does Humacyte Make?

Data Unavailable

Is Humacyte Growing As A Company?

Data Unavailable

Humacyte Stock Price Performance

  • Did Humacyte Stock Go Up Last Month?
    Humacyte share price went down by -23.22% last month
  • Did HUMA's Share Price Rise Over The Last Year?
    HUMA share price rose by 40.89% over the past 1 year

What Is Humacyte 52-Week High & Low?

  • What Is Humacyte’s 52-Week High Share Price?
    Humacyte has traded as high as $9.97 over the past 52 weeks
  • What Is Humacyte’s 52-Week Low Share Price?
    Humacyte has traded as low as $2.48 over the past 52 weeks

Humacyte Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Humacyte?

  • How Much Debt Does Humacyte Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Humacyte Have?
    Cash and short term investments quarterly total is $20.6M
  • What Is Humacyte’s Book Value Per Share?
    Book value per share is -0.53

Is Humacyte Cash Flow Positive?

  • What Is HUMA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$90.6M
  • What Is Humacyte’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $62.8M
  • What Is Humacyte’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$1.7M

Humacyte Return On Invested Capital

Data Unavailable

Humacyte Earnings Date & Stock Price

  • What Is Humacyte's Stock Price Today?
    A single share of HUMA can be purchased today for 4.10
  • What Is Humacyte’s Stock Symbol?
    Humacyte trades on the nasdaq under the ticker symbol: HUMA
  • When Is Humacyte’s Next Earnings Date?
    The next quarterly earnings date for Humacyte is scheduled on March 21, 2025
  • When Is HUMA's next ex-dividend date?
    Humacyte's next ex-dividend date is December 15, 2024
  • How To Buy Humacyte Stock?
    You can buy Humacyte shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Humacyte Competitors

  • Who Are Humacyte's Competitors?
    Below is a list of companies who compete with Humacyte or are related in some way:
    • iBio Inc (IBIO)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Oragenics Inc (OGEN)
    • Palatin Technologies Inc (PTN)
    • Theriva Biologics Inc (TOVX)

Humacyte Dividend Yield

  • What Is HUMA Dividend Yield?
    Humacyte’s dividend yield currently is 0%
  • What Is Humacyte’s Payout Ratio?
    Humacyte’s payout ratio is 0%
  • When Did Humacyte Last Pay A Dividend?
    The latest dividend pay date is December 15, 2024
  • What Is Humacyte’s Dividend Per Share?
    Humacyte pays a dividend of $0.00 per share

Humacyte Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -4.98%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 13.00
Upside from Last Price: 217.07%

Major Shareholders

  • How many HUMA shares are owned by institutional investors?
    50.7M HUMA shares are owned by institutional investors
  • How many HUMA shares are owned by insiders?
    1.1M HUMA shares are owned by insiders